CELLDEX THERAPEUTICS INC NEW - COM (CLDX)

CUSIP: 15117B103

Q4 2013 13F Holders as of 31 Dec 2013

Type / Class
Equity / COM
Total 13F shares
75,788,346
Share change
+821,562
Total reported value
$1,835,148,103
Put/Call ratio
83%
Price per share
$24.21
Number of holders
158
Value change
+$19,887,297
Number of buys
2
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP 15117B103?
CUSIP 15117B103 identifies CLDX - CELLDEX THERAPEUTICS INC NEW - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CELLDEX THERAPEUTICS INC NEW - COM (CLDX) as of Q4 2013

As of 31 Dec 2013, CELLDEX THERAPEUTICS INC NEW - COM (CLDX) was held by 158 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 75,788,346 shares. The largest 10 holders included FMR LLC, FRANKLIN RESOURCES INC, VANGUARD GROUP INC, JENNISON ASSOCIATES LLC, OPPENHEIMER FUNDS INC, SAC Capital Advisors LP, BlackRock Fund Advisors, BlackRock Institutional Trust Company, N.A., Sectoral Asset Management Inc, and TimesSquare Capital Management, LLC. This page lists 158 institutional shareholders reporting positions in this security for the Q4 2013 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.